Collection: Lucius Pharmaceuticals
-
Ponatinib 15mg Ponatinib is a kinase inhibitor indicated for the treatment of adult patients with chronic myeloid leukemia (CML) in chronic phase (CP).
Regular price ¥630.00 CNYRegular priceUnit price / per¥1,000.00 CNYSale price ¥630.00 CNYSale -
Lenvatinib is indicated for the treatment of hepatocellular carcinoma, renal cell carcinoma, differentiated cancer, and endometrial cancer.
Regular price ¥300.00 CNYRegular priceUnit price / per¥450.00 CNYSale price ¥300.00 CNYSale -
Vigabatrin/vigabatrin is indicated as monotherapy for children with infantile spasms (IS) when the potential benefit of treatment outweighs the potential risk of visual impairment.
Regular price ¥650.00 CNYRegular priceUnit price / per¥800.00 CNYSale price ¥650.00 CNYSale -
Stiripentol is used to treat seizures associated with Dravet syndrome (DS) in patients 6 months of age and older weighing ≥7 kg taking clobazam.
Regular price ¥2,500.00 CNYRegular priceUnit price / per¥4,200.00 CNYSale price ¥2,500.00 CNYSale -
Enrectinib is a specific tyrosine kinase inhibitor designed for the fusion of NTRK and ROS1 genes, used to treat NTRK fusion-positive locally advanced or metastatic solid tumors.
Regular price ¥1,275.00 CNYRegular priceUnit price / per¥2,300.00 CNYSale price ¥1,275.00 CNYSale -
阿布昔替尼 用于治疗12岁及以上患有难治性、中度至重度特应性皮炎的成人和儿童患者,这些患者的疾病不能用其他全身性药物(包括生物制品)充分控制,或者不建议使用这些疗法。
Regular price ¥460.00 CNYRegular priceUnit price / per¥580.00 CNYSale price ¥460.00 CNYSale -
Vibergron is indicated for the treatment of overactive bladder (OAB) in adults with symptoms of acute urinary incontinence, urgency, and frequency.
Regular price ¥1,125.00 CNYRegular priceUnit price / per¥1,600.00 CNYSale price ¥1,125.00 CNYSale -
Ibrutinib is for adult patients with mantle cell lymphoma (MCL) who have received at least one prior treatment. 3% customs VAT for export to China
Regular price ¥825.00 CNYRegular priceUnit price / per¥1,500.00 CNYSale price ¥825.00 CNYSale -
Molotinib is indicated for the treatment of anemia in adult patients with intermediate- or high-risk myelofibrosis (MF), including primary myelofibrosis or secondary myelofibrosis [polycythemia vera (PV) and essential thrombocythemia (ET)].
Regular price ¥1,800.00 CNYRegular priceUnit price / per¥2,800.00 CNYSale price ¥1,800.00 CNYSale -
Pitobrutinib is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inhibitor.
Regular price ¥2,400.00 CNYRegular priceUnit price / per¥5,000.00 CNYSale price ¥2,400.00 CNYSale -
LuciVemu Vemurafenib 240mg 56 tablets exported to China 3% customs VAT
Regular price ¥2,300.00 CNYRegular priceUnit price / per¥3,000.00 CNYSale price ¥2,300.00 CNYSale -
Ceritinib is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) that is positive for anaplastic lymphoma kinase (ALK) as detected by an FDA-approved test.
Regular price ¥1,170.00 CNYRegular priceUnit price / per¥1,600.00 CNYSale price ¥1,170.00 CNYSale -
Serpatinib is indicated for: 1. Metastatic RET fusion-positive non-small cell lung cancer 2. Ret mutation medullary thyroid cancer 3. RET-positive thyroid cancer
Regular price ¥2,400.00 CNYRegular priceUnit price / per¥4,300.00 CNYSale price ¥2,400.00 CNYSale -
Alectinib is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.
Regular price ¥1,275.00 CNYRegular priceUnit price / per¥1,800.00 CNYSale price ¥1,275.00 CNYSale -
Trelagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
Regular price ¥360.00 CNYRegular priceUnit price / per¥600.00 CNYSale price ¥360.00 CNYSale -
Afatinib LuciAfa Afatinib 40mg 30 tablets exported to China 3% customs VAT
Regular price ¥600.00 CNYRegular priceUnit price / per¥900.00 CNYSale price ¥600.00 CNYSale